CD47 as a potent target in cancer immunotherapy: A review


Journal article


Hiva Ahvati, Raheleh Roudi, Navid Sobhani, Fatemeh Safari
Biochim Biophys Acta Rev Cancer, vol. 1880(2), 2025


Cite

Cite

APA   Click to copy
Ahvati, H., Roudi, R., Sobhani, N., & Safari, F. (2025). CD47 as a potent target in cancer immunotherapy: A review. Biochim Biophys Acta Rev Cancer, 1880(2). https://doi.org/10.1016/j.bbcan.2025.189294


Chicago/Turabian   Click to copy
Ahvati, Hiva, Raheleh Roudi, Navid Sobhani, and Fatemeh Safari. “CD47 As a Potent Target in Cancer Immunotherapy: A Review.” Biochim Biophys Acta Rev Cancer 1880, no. 2 (2025).


MLA   Click to copy
Ahvati, Hiva, et al. “CD47 As a Potent Target in Cancer Immunotherapy: A Review.” Biochim Biophys Acta Rev Cancer, vol. 1880, no. 2, 2025, doi:10.1016/j.bbcan.2025.189294.


BibTeX   Click to copy

@article{hiva2025a,
  title = {CD47 as a potent target in cancer immunotherapy: A review},
  year = {2025},
  issue = {2},
  journal = {Biochim Biophys Acta Rev Cancer},
  volume = {1880},
  doi = {10.1016/j.bbcan.2025.189294},
  author = {Ahvati, Hiva and Roudi, Raheleh and Sobhani, Navid and Safari, Fatemeh}
}